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Abstract
Background:  Systemic sclerosis (SSc), a progressive disease characterized by excessive
accumulation of connective tissue components. Although most patients have long survival, some of
them progress rapidly to death. Pulmonary system involvement and pulmonary hypertension are
the most frequent cause of death. When the patient with SSc is to be operated, the anesthetic
procedure could be a serious problem. In this article, we report a combined spinal – epidural
technique in a patient with progressive SSc and the anesthetic considerations that could be
recommended for these patients.
Case presentation: A 68-year-old woman who had a history of progressive systemic sclerosis,
pulmonary fibrosis, kyphoscoliosis and decreased oral apertura underwent total hip arthroplasty.
This operation was performed successfully under combined spinal epidural anesthesia.
Conclusion: Systemic sclerosis is a complex disease that involves multiple organ systems. Every
aspects of anesthetic care may be altered or hindered by the pathogenesis of disease. Although the
choice of regional or general anesthesia is unclear, to choose combined spinal epidural anesthesia
may be useful.
Background
Systemic sclerosis, also termed 'scleroderma' is a multsys-
tem- connective tissue disease, characterized by excessive
fibrosis, vascular abnormalities, and immune dysfunc-
tion. A relatively rare syndrome, scleroderma has an
annual incidence of 1 or 2 cases per 100 000 and 3 times
more frequent in women than men. The usual onset is
between 30 to 50 years of age. Muscles, bones, mucous
membranes, heart, lungs, intestinal tract and other inter-
nal organs may be involved [1]. Kidney, lung and heart
involvement is associated with poor prognosis; moreover
visceral involvement and immunological findings have
been considered as prognostic factors by some authors
[2]. Sixty percent of deaths are secondary to heart or lung
involvement and (or) to pulmonary hypertension[3].
It is reported that, anesthesiologists managing patients
with SSc intraoperatively must have experience and back-
ground about the pathogenesis, clinical manifestations,
systemic involvement and anesthetic considerations. One
should never forget that every aspects of anesthetic care
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may be altered or hindered by the pathogenesis of this dis-
ease [4].
In this report we present a very rare case of combined spi-
nal-epidural anesthesia in a patient with SSc whose pul-
monary function tests were decreased with low exercise
capacity.
Case presentation
A 68 year-old woman, 150-cm in height, weighing 45-kg
with traumatic left femur fracture admitted to the hospital
for total hip arthroplasty. She had been diagnosed of SSc
ten years ago. Before surgery she was receiving deflazacort
13.5 mg/day every other day, pentoxifyllin 400 mg/day,
acetylsalicylic acid 300 mg/day, cyclophosphamide 50
mg/day, colchicine 1 mg/day and risedronate sodium 35
mg/week. Deflazacort, acetylsalicylic acid, cyclophospha-
mide and colchicine were quited preoperatively.
On her physical examination, she has waxy, smooth and
tight skin, decreased oral aperture (3 cm) and thyromen-
tal distance was 6 cm, the patient was almost bedridden
secondary to severe flexion contractures of all four extrem-
ities. She had borderline hypertension (150/90 mmHg).
She had chronic cough with bilaterally reduced lung
sounds. Inspection of her back revealed kyphoscoliosis.
Because of severe dyspne, she had echocardiyagram, the
result was compatible with normal left ventricular size
and contractility, minimal right atrial enlargement, mini-
mal dilated hypo kinetic right ventricle. Bibasal pulmo-
nary fibrosis was detected on her chest radiogram. The
arterial blood gases and pulmonary function tests result
were as fallow; fraction of inspired oxygen 0.21, PaO2 :
88.6 mmHg, PaCO2 : 18.8 mmHg, and pH: 7,51; forced
expiratory volume in 1st second (FEV1):1,5 L, forced vital
capacity (FVC): 1.9 L, total lung capacity 2,95 L. The liver
and renal function tests were normal. The complete blood
caunt was as follows. Hemoglobin:10.5 g/dl, platelet (plt)
: 202 K/uL, protrombine time (PT):11.88 s (range:11.5–
15 s) and activated partial thromboplastin time (aPTT):
23.22s (range: 20–33 s).
The patient received 150 mg of ranitidine and 10 mg of
metoclopramide thirty minutes before the regional block.
In the operation room, arterial blood pressure (BP) was
153/92 mmHg, and her heart rate (HR)was 95 bpm. A 16
gauge venflon catheter was inserted into a vein in the dor-
sum of right hand, and 500 ml of 0.9 % NaCl solution was
infused over the next 20 min. Standard monitoring was
used throughout the procedure, including continuous
ECG (Lead II), heart rate, non-invasive arterial blood pres-
sure measured in every five minutes and continuous pulse
oximetry. A senior experienced anesthesiologist per-
formed the combined spinal- epidural (CSE) anesthesia.
The patient was placed in the left side position and a dis-
posable 16 gauge Toughy needle (portex) was introduced
trough the L2/L3 epidural space under full aseptic condi-
tion without difficulty. The epidural space was located 5
cm from the skin via the loss of resistance technique with
the midline approach. Then after 25 gauge 123 mm
Whitacre spinal needle was inserted through the epidural
needle, and free – flow of cerebrospinal fluid (CSF) was
observed. Hyperbaric bupivacaine 0.5% 12.5 mg was
injected over 30 sec without further CSF aspiration (speed
of intrathecal injection approximately 0.05 ml.sec-1). Epi-
dural catheter was inserted for the management of post-
operative pain. The catheter was secured at 3 cm in the
epidural space. Nothing was injected trough the catheter
at this stage. The patient was kept in the left side position
for 15 min.
The sensory block was evaluated by the pinprick test (22-
gauge hypodermic needle), whereas motor block was
evaluated by a modified Bromage scale (0 : no motor
block; 1: hip block; 2: hip and knee block; 3 : hip, knee
and ankle block). Ten minutes after the injection of local
anesthetic solution, the sensory block level reached bilat-
erally to T8 dermatome level and the motor block level
reched to Bromage 3 on both lower extremities.
Then, the patient was positioned supine on the operating
table and surgery started at the 15th min. In order to avoid
the vasospasm of Reynaud's phenomenon; the tempera-
ture of the operating room was kept at 24°C and intra
arterial cannula wasn't inserted.
Estimated blood loss during 70 min. surgery was minimal
(approximately 250 ml). In addition to infused metil-
prednisolon 20 mg/six hours and regular insulin 8 IU/six
hours, total fluids given during surgery was 2500 ml of
0.9% NaCl. There was no remarkable variation on hemo-
dynamic and SpO2 values with respect to baseline values
throughout the procedure.
After the spinal injection, the motor block was completely
regressed at 195th min and the sensory block was regressed
at 225th min. Because the patient appeared to be pain free
in recovery room, nothing was given through the epidural
catheter. The patient had been monitorized in post anes-
thetic care unit for 2 days, and catheter was removed on
postoperative day 2. Then, she was transferred to the
orthopedic ward. She was discharged from the hospital at
postoperative day 14 uneventfully.
Discussion
Although systemic sclerosis has been characterized as
both localized and generalized forms, the spectrum of dis-
ease ranges from mild Reynolds's phenomenon to diffuse
skin and visceral involvement [1]. Excessive accumulation
of connective tissue components and structural vascularBMC Anesthesiology 2006, 6:11 http://www.biomedcentral.com/1471-2253/6/11
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abnormalities have variable natural histories. Although
most patients have long survival expectancy, minority of
them progress to death because of the visceral involve-
ment which contains dermal thickening, restrictive pul-
monary disease, cutaneous calcification, congestive heart
failure secondary to pulmonary hypertension, myocardi-
tis, cardiac conduction abnormalities, diminished renal
clearance of drugs, and lower esophageal sphincter dilata-
tion. We know that all above conditions can contribute to
many serious anesthesia related complications [3-5].
The clinical presentations of SSc and some anesthetic
implications have been reviewed in a few articles[4,5].
And there are some published case reports on anesthesia
techniques for the patients with SSc, but there isn't unique
suggested technique for these patients. General anesthesia
can lead to various problems such as difficulty of intuba-
tion and insertion of an iv cannula or measuring blood
pressure. Moreover it was declared that performing a tra-
cheotomy may be difficult because of sclerotic changes in
the head and neck region [5].
As far as we know, there are three case reports in Medline
about scleroderma. Both of them had preeclempsia and
they were operated under general anesthesia. Unfortu-
nately, one of them died because of pulmonary edema,
pulmonary hypertension, sepsis and thrombocytopenia
[6,7]. In another paper Bailey et al. reported that spinal
anesthesia can be used for caesarean section in a patient
with systemic sclerosis [8].
Regional anesthesia is frequently used in elderly patients
undergoing surgery. Although the type of anesthesia has
no substantional effect on peroperative morbidity and
mortality, it makes sense that elderly patients would ben-
efit from regional anesthesia because they remain awake
throughout the procedures and obtain excellent postoper-
ative pain control [9]. It should be kept in mind that,
unpredictable spread and prolonged duration of action of
local anesthetics may occur and regional anesthesia may
be unacceptable for the patients with SSc[7,10]. In ' diffi-
cult to entubate ' cases despite the presence of high risk of
spinal anesthesia some authors recommend regional
anesthesia for patients with severe SSc [5,7]. In addition to
this, it is widely believed that regional anesthesia has ben-
efit for patients with severe pulmonary disease. Harald et
al. reported that, even high thoracic regional anesthesia is
well tolerated in patients with severe pulmonary disease,
although FEV1 and vital capacity may be slightly decreased
[11].
On the other hand, interstitial lung disease is reported to
occur, in up to 80% of patients with scleroderma.
Although, in the majority of the patients, the interstitial
lung involvement is sub clinical and asymptomatic in the
early stage; clinically significant interstitial lung disease is
observed in approximately 40% of patients with systemic
sclerosis and is a leading cause of morbidity and mortality
[12].
Most experts rely on a combination of pulmonary func-
tional tests for diagnosis of interstitial lung disease of SSc
[12]. Pulmonary involvement is considered on the evi-
dence of bibasal pulmonary fibrosis on chest radiogram
or pulmonary functional tests (PFT) alteration (restrictive,
obstructive or mixed pattern) on spirometry or less than
70% of predicted carbon monoxide diffusing capacity or
the presence of all. Clinically significant restrictive lung
disease is defined when an abnormal FVC with normal
FEV1/FVC is observed [2]. In this patient, bibasal pulmo-
nary fibrosis was seen on chest radiogram, and pulmonary
functional tests (PFT) had alterations (restrictive or mixed
pattern).
In our patient, because of the restricted oral aperture and
decreased mandible – sternum distance and lung involve-
ment we thought that regional anesthesia could be a bet-
ter choice. Continuous spinal anesthesia techqnique
(CSA) is recommended for diagnosis and treatment
before peripheral sympathectomy in patients with sec-
ondary Reynoud's phenomenon and scleroderma [13]. So
a carefully titrated continuous spinal anesthesia might
have been chosen. However it was mentioned that the
incidence of postoperative neurological deficits (such as
headache, transient neurologic symptoms, cauda equina
syndrome or meningitis) is significantly increased, fol-
lowing CSA technique [14,15] ; furthermore our patient
needed only total hip arthroplasty and we were inexperi-
enced on performing CSA technique. On account of these
reasons combined spinal – epidural technique was cho-
sen.
Preoperatively, drugs were administered to reduce the risk
of aspiration and an ENT surgeon was available in the
operating room for an urgent tracheotomy. In fact CSE
technique was our first choice in this patient. Because of
her flexion contractures and xifoscoliosis, it wouldn't have
been performed. But we didn't face with any difficulty
while performing CSE. It is known that, the difference
between densities of cerebrospinal fluid and the solution
injected has a major effect on intrathecal drug distribution
[16]; for protecting the patient from the risk of bilaterally
high spinal anesthesia, we used hyperbaric bupivacaine
and kept the patient in the left side position after the spi-
nal injection for 15 min. Generally, if the patient is kept
in this position for 5 min. following injection, the block
tends to be denser and achieve a high level on the opera-
tive side. But, in our patient, although the level of block
was approximately at T8 level unexpectedly the block was
bilateral. Although regional anesthesia may cause pro-Publish with BioMed Central    and   every 
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longed duration of action of local anesthetics in patients
with scleroderma; in our patient the duration of local
anesthetic was similar to McNamee's results. According to
their results, when bupivacaine is used, duration of sen-
sory block varies from 1.5 h to 4.6 h in patients without
scleroderma [17].
Conclusion
In respect of absence consensus and guidelines, the choice
of regional or general anesthesia is unclear, this report
describes the successful use of CSE technique in a patient
with SSc and respiratory impairment. We concluded that
the choice of anesthetic technique for patients with SSc
should be made on an individualized basis, including an
evaluation of the extent of the disease, technique and con-
sideration of the surgical procedure, the circumstances of
operating room and the choice of the patient.
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